Zhongchao Inc (ZCMD) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Zhongchao Inc $0.27, price $1.85, upside -85.6%, quality 35 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Structural break:
The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.
Weakest SetupStrongly overvalued and low quality.
!Fair value $0.2674 · Strongly overvalued (−85.6%)
!Quality 35/100
!Weak Growth(revenue 5y −8.8 %/yr)
!Loss-making · -55.5% net margin (TTM)
✓generates free cash flow
!Trails peers(0/7)
!Narrow moat9/100
!Evidence only low, so the estimate is less certain
Watch Zhongchao Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range $0.3640 – $4,779 · fair‑value band $0.2319 – $0.3275 · the $1.85 price screens above the $0.2674 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow Zhongchao in your weekly email
Every Wednesday you see whether Zhongchao is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs.
Show more
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.
Stock analysis
Zhongchao Inc (ZCMD) currently trades at $1.85, while our model-based Fair Value estimate is $0.2674, 85.6% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 7 models at a data quality of 80/100, which puts the evidence level at low.
Scenario range: $0.2319 (bear) to $0.3275 (bull), the price of $1.85 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 35/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Zhongchao Inc reported revenue of $11.4M in FY2025 versus $16.3M in FY2021, a compound −8.6%/yr. Reported net income was −$6.3M in FY2025.
Key figures
Market cap $1.4M · P/S ratio 0.13 · EPS (TTM) $−57.35 · Net margin −55.5% · Return on equity −24.9% · Return on assets (EBIT) −17.9% · Operating margin −92.0% · Revenue (TTM) $11.4M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (medium confidence).
What moves the price
The share trades about 99% below its 52-week high and 408% above its 52-week low.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −86%, ZCMD screens richer than that median.
Fair Value models
Bear $0.2319Fair Value $0.2674Bull $0.3275
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.18/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−28.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−8.8%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.9%
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
25.0% (2020) → −54.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 128 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Zhongchao Inc Fair Value". https://www.fairvalue-calculator.com/stock/ZCMD
Frequently asked questions
Is Zhongchao Inc (ZCMD) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.2674 versus a price of $1.85, about −86% upside (overvalued).
What is the fair value of ZCMD?
Our model-based fair value for Zhongchao Inc is $0.2674 (as of Sep 27, 2026), built from audited fundamentals. The current price: $1.85.
What is the quality score of ZCMD?
Zhongchao Inc has a Quality Score of 35/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Zhongchao Inc (ZCMD)?
Our model-based price target is the fair value of $0.2674 (as of Sep 27, 2026) from 7 valuation models. Cautious scenario $0.2319, optimistic scenario $0.3275. It is a calculation from audited fundamentals, not an analyst target.
What is the Zhongchao Inc stock forecast for 2026?
Our models put fair value at $0.2674, about −86% upside versus a price of $1.85 (overvalued). Cautious scenario $0.2319, optimistic scenario $0.3275. The calculation is refreshed regularly with new filings.
What is the revenue of Zhongchao Inc (ZCMD)?
Zhongchao Inc reported trailing-twelve-month revenue of about $11.4M (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of Zhongchao Inc (ZCMD)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Zhongchao Inc it is $0.2674 per share (as of Sep 27, 2026), against a price of $1.85. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is Zhongchao Inc stock overvalued or undervalued in 2026?
As of Sep 27, 2026, ZCMD trades above its calculated fair value: price $1.85, fair value $0.2674, a gap of about −86% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ZCMD?
No. The price is what the market pays today ($1.85); the fair value is what the company's own numbers justify ($0.2674). For Zhongchao Inc the two are $1.58 per share apart. That gap is exactly why we show both numbers side by side.
How much is Zhongchao Inc worth?
The market values Zhongchao Inc at about $1.4M (market capitalisation, as of Sep 27, 2026). Per share that is $1.85; our models calculate a fair value of $0.2674 per share.
What do the bullish and bearish scenarios say about ZCMD?
Our models span a range for Zhongchao Inc: cautious scenario $0.2319, base $0.2674, optimistic $0.3275 per share (as of Sep 27, 2026, price $1.85). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Zhongchao Inc (ZCMD)?
Balance-sheet figures for Zhongchao Inc (as of Sep 27, 2026): return on equity −24.9%. They feed the Quality Score of 35/100, which measures business quality independently of the share price.
How far is ZCMD from its 52-week high?
Zhongchao Inc trades at $1.85, about 99% below its 52-week high of $310.00 and 408% above the low of $0.3640 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $0.2674 is for.
Which stocks are comparable to Zhongchao Inc?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Zhongchao Inc stock attractive at the current price?
The data as of Sep 27, 2026: price $1.85, calculated fair value $0.2674 (−86%), Quality Score 35/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ZCMD calculated?
We run Zhongchao Inc through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.2674, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Zhongchao Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Zhongchao Inc (ZCMD)?
The closing price on Oct 2, 2026 was $1.85. Our model-based fair value is $0.2674, about −86% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Zhongchao Inc right now?
The price sits above even our optimistic bull case ($0.3275). The favourable scenario is already priced in. Weak quality (35/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Zhongchao Inc
How large is the market capitalisation of Zhongchao Inc (ZCMD)?
The market capitalisation of Zhongchao Inc is $1.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Zhongchao Inc (ZCMD)?
The price-to-sales ratio of Zhongchao Inc is 0.13 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Zhongchao Inc (ZCMD)?
Earnings per share at Zhongchao Inc are $−57.35. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Zhongchao Inc (ZCMD)?
The net margin of Zhongchao Inc is −55.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Zhongchao Inc (ZCMD)?
The return on equity (ROE) of Zhongchao Inc is −24.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Zhongchao Inc (ZCMD)?
On an EBIT basis the return on assets of Zhongchao Inc is −17.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Zhongchao Inc (ZCMD)?
The operating margin of Zhongchao Inc is −92.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Zhongchao Inc (ZCMD)?
Revenue at Zhongchao Inc is growing −23.2% versus a year earlier (3y avg −7.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Zhongchao Inc (ZCMD)?
Earnings per share at Zhongchao Inc are growing −91.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Zhongchao Inc (ZCMD) generate?
The free cash flow of Zhongchao Inc is $693K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Zhongchao Inc (ZCMD) hold?
Zhongchao Inc holds more cash than debt, $8.1M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Zhongchao Inc in the live analysis
One click puts Zhongchao Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 27, 2026